1. Home
  2. TMP vs OGN Comparison

TMP vs OGN Comparison

Compare TMP & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tompkins Financial Corporation

TMP

Tompkins Financial Corporation

HOLD

Current Price

$100.99

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.72

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMP
OGN
Founded
1836
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
TMP
OGN
Price
$100.99
$13.72
Analyst Decision
Hold
Hold
Analyst Count
1
5
Target Price
$87.00
$11.40
AVG Volume (30 Days)
83.7K
2.6M
Earning Date
04-24-2026
05-07-2026
Dividend Yield
3.21%
0.60%
EPS Growth
126.16
N/A
EPS
3.86
0.95
Revenue
$75,742,000.00
$6,216,000,000.00
Revenue This Year
N/A
$0.45
Revenue Next Year
$7.94
$1.67
P/E Ratio
$25.99
$14.38
Revenue Growth
N/A
N/A
52 Week Low
$61.88
$5.69
52 Week High
$102.02
$13.70

Technical Indicators

Market Signals
Indicator
TMP
OGN
Relative Strength Index (RSI) 61.77 76.11
Support Level $91.10 $13.46
Resistance Level $102.02 N/A
Average True Range (ATR) 2.27 0.04
MACD -0.17 0.01
Stochastic Oscillator 81.69 97.62

Price Performance

Historical Comparison
TMP
OGN

About TMP Tompkins Financial Corporation

Tompkins Financial Corp is a Financial Holding Company. The company manages its operations through two business segments, consisting of banking and wealth management. It offers various products and services, including commercial and consumer banking, leasing, trust and investment management, financial planning and wealth management, and insurance. Wealth management activities include the results of the company's trust, financial planning, and wealth management services. The company generates the majority of its revenue from the Banking segment.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: